ASX Share rice
Fri 14 Aug 2020 - 09:50:pm (Sydney)

OBJ Share Price

OBJ LIMITEDOBJPharmaceuticals, Biotechnology & Life Sciences

OBJ Company Information

Name:

OBJ Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

284 Oxford Street Leederville WA Australia 6007

Phone:

61 8 9443 3011

Founder, MD, Technical Director & Exec. Director:

Mr. Jeffrey David Edwards

Chief Exec. Officer:

Mr. Paul Peros

Chief Scientific Officer:

Dr. Matthew McIldowie

Company Sec.:

Mr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr

Scientific Adviser:

Dr. Michael Roberts

Company Overview:

OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.

OBJ Share Price Information

Shares Issued:

90.47M

Dividend Yield:

%

Revenue (TTM):

$1.98M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.001

Profit Margin:

-1.0638

Operating Margin (TTM):

$-1.05

Return On Assets (TTM):

$-0.39

Return On Equity (TTM):

$-0.89

Quarterly Revenue Growth (YOY):

-0.689

Gross Profit(TTM):

$2.46M

Diluted Earnings Per Share (TTM):

$-0.025

OBJ CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$25.67K

Total Cashflow From Investing Activities:

$-21,362

Net Income:

$-1,710,001

Total Cash From Operating Activities:

$-1,876,400

Depreciation:

$72.88K

Change To Account Receivables:

$-305,904

Capital Expenditures:

$21.36K

OBJ Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-1,710,001

Net Income:

$-1,710,001

Gross Profit:

$2.46M

Operating Income:

$-1,669,600

Other Operating Expenses:

$329.59K

Interest Expense:

$-14,011

Total Revenue:

$2.74M

Total Operating Expenses:

$4.41M

Cost Of Revenue:

$284.95K

OBJ Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$591.16K

Total Stockholder Equity:

$2.55M

Total Assets:

$3.14M

Common Stock:

$33.04M

Retained Earnings:

$-30,730,440

Cash:

$2.25M

Total Current Liabilities:

$591.16K

Property - Plant & Equipment:

$323.85K

Net Tangible Assets:

$2.55M

Total Current Assets:

$2.81M

Net Receivables:

$519.43K

Accounts Payable:

$255.16K

OBJ Share Price History

OBJ News

13 Jan, 2020
Little Green Pharma Ltd (“LGP”) has applied to list on the ASX, with a target listing date of February 7th, 2020 under the symbol ‘LGP’. Elixxer is currently the largest shareholder and supports LGP’s expansion plan throughout Australia and international markets into Europe. LGP is currently expanding operations in Australia to increase their current production from 15,000 bottles of medical cannabis oil per year to over 110,000 bottles.
03 Oct, 2019
The CEO of OBJ Limited (ASX:OBJ) is Jeff Edwards. First, this article will compare CEO compensation with compensation...